Comparison of Physical Performance, Balance, and Functional Mobility Parameters According to Walking Speed in Geriatric Individuals
25 de abril de 2026 actualizado por: Gulfidan Tokgoz, Istanbul University - Cerrahpasa
Comparison of Physical Performance, Balance, and Functional Mobility Parameters According to Walking Speed Threshold Values in Geriatric Individuals
The aim of this study is to examine the determining role of walking speed on physical performance parameters in individuals aged 65 and over.
The study aims to compare flexibility, lower extremity muscle strength (5-count sit-stand test), static balance (single-leg balance), upper extremity muscle strength (hand grip), dynamic balance (FUT), functional mobility (TUG), and stair climbing/climbing skills in individuals with walking speeds of 0.4-0.8
m/s (limited community mobility) and above 0.8 m/s (independent community mobility).
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Intervención / Tratamiento
Descripción detallada
Although the relationships between walking speed and individual physical parameters have been studied in the geriatric literature, comprehensive analyses comparing multidimensional parameters such as flexibility, static-dynamic balance, hand grip strength, and stair activity performance in groups separated according to walking speed threshold values (0.4-0.8 m/s and >0.8 m/s) are needed.
This study aims to identify which physical components show the most significant deficits when walking speed decreases, thereby providing a scientific basis for clinical assessment processes and personalized preventive rehabilitation programs.
Tipo de estudio
De observación
Inscripción (Estimado)
76
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: GULFİDAN TOKGÖZ, Lecturer, PhD (c)
- Número de teléfono: 0552 022 76 32
- Correo electrónico: gulfidan.tokgoz@gmail.com
Ubicaciones de estudio
-
-
-
Balıkesir, Turquía (Türkiye)
- Balıkesir University
-
Contacto:
- GULFİDAN TOKGÖZ, Lecturer, PhD (c)
- Número de teléfono: 0552 022 76 32
- Correo electrónico: gulfidan.tokgoz@gmail.com
-
Sub-Investigador:
- Bilal Katipoğlu, Assoc. Prof. Dr.
-
Contacto:
- Nilay ARMAN, Assoc. Prof. Dr.
- Número de teléfono: +905534558707
-
Sub-Investigador:
- Saime Nilay Arman, Assoc. Prof. Dr.
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Método de muestreo
Muestra de probabilidad
Población de estudio
Geriatric individuals aged 65 and over who meet the inclusion criteria for the study.
Descripción
Inclusion Criteria:
- Being 65 years of age or older
- Being able to perform walking functions
- Having sufficient mobility to perform the physical performance tests included in the research, such as 5 sit-stand tests, TUG (Trip and Go) tests, and stair climbing/descending tests. • Having a walking speed of at least 0.4 m/s or more as a result of the 4 Meter Walking Test (having limited or independent mobility within the community).
- Voluntarily agreeing to participate in the study and providing informed consent.
Exclusion Criteria:
- Having a history of advanced cognitive impairment or diagnosed dementia that would impair the ability to understand and follow test instructions.
- Those diagnosed with moderate or severe cognitive impairment (MMSE < 24 and/or MoCA < 21)
- Having a walking speed below 0.4 m/s on the 4-Meter Walk Test (individuals who are wheelchair-bound or bedridden).
- Advanced Parkinson's disease, active stroke sequelae, lower extremity fracture within the last 6 months, or a history of acute orthopedic surgery that primarily affects motor performance and balance.
- Those with severe hearing or vision loss
- Individuals experiencing significant difficulty communicating
- Participants who did not sign the voluntary consent form
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
Geriartric Indivıduals
Geriatric individuals aged 65 and over who meet the inclusion criteria for the study.
|
Assessments will be conducted after obtaining voluntary consent from the participants.
The physical performance tests to be applied within the scope of the research will be carried out by the research team within the framework of internationally accepted standard protocols whose validity and reliability have been proven in the geriatric population.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
4-Meter Walk Test (Walking Speed Measurement)
Periodo de tiempo: 1 week
|
Walking speed will be assessed using the 4-Meter Walk Test, a key indicator of functional mobility in geriatric individuals.
Participants will be asked to walk a 4-meter test area in the center at their "natural and comfortable walking speed," using 1-meter "acceleration" zones at the beginning and 1-meter "deceleration" zones at the end of a 6-meter flat course.
The measurement will be recorded with a stopwatch the moment the participant's foot crosses the 4-meter marked area, and the result will be calculated in m/s (Studenski et al., 2011).
|
1 week
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Time Sit-Stand Test (5STS):
Periodo de tiempo: 1 week
|
To assess lower extremity muscle strength and balance, participants will be asked to stand up and sit down as quickly as possible, five times consecutively, from a standard chair 43-45 cm high, with their arms crossed over their chest.
The timer will start with the "start" command and end when the fifth sitting is completed (Bohannon, 2006).
|
1 week
|
|
Timed Up and Go (TUG):
Periodo de tiempo: 1 week
|
To measure functional mobility, the participant will get up from the chair, walk a distance of 3 meters, return, and sit back down in the chair.
This time will be recorded in seconds using a stopwatch (Podsiadlo & Richardson, 1991).
|
1 week
|
|
Functional Reach Test (FUT/FRT)
Periodo de tiempo: 1 week
|
To measure static balance and stability limits, the maximum distance the participant can reach without losing balance and without taking a step, while standing next to a wall with the shoulder flexed at 90 degrees, will be measured (Duncan et al., 1990).
|
1 week
|
|
Single Leg Balance Test (Right and Left):
Periodo de tiempo: 1 week
|
Participants' static balance will be determined by recording the "time they can stand on one leg" (maximum 60 seconds) with their eyes open and hands on their hips, on both their dominant and non-dominant legs (Springer et al., 2007).
|
1 week
|
|
Flexibility (Sit-and-Reach Test):
Periodo de tiempo: 1 week
|
To measure hamstring and lower back flexibility, the participant will sit in a long, straight position, reaching forward without bending their knees.
The distance reached by their fingertips will be recorded on a "sit-and-reach bench" (Wells & Dillon, 1952).
|
1 week
|
|
Stair Climbing Test
Periodo de tiempo: 1 week
|
To assess high-level mobility, participants will be recorded in seconds for safely and as quickly as possible ascending and descending a staircase of standard step height [a specified number of steps, e.g., 10 steps] (Nightingale et al., 2003).
|
1 week
|
|
Strength Measurement (Hand Grip Strength):
Periodo de tiempo: 1 week
|
Upper extremity muscle strength will be measured using a digital hand dynamometer according to the ASHT (American Society of Hand Therapists) protocol.
Participants will be asked to grip with maximum force while sitting upright, with shoulder adduction and elbow 90 degrees flexed.
Three repetitions will be performed for each hand, and the average of these measurements in kilograms (kg) will be included in the analysis (Roberts et al., 2011; Cruz-Jentoft et al., 2019).
|
1 week
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Publicaciones Generales
- Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, Cesari M, Donini LM, Gillette Guyonnet S, Inzitari M, Nourhashemi F, Onder G, Ritz P, Salva A, Visser M, Vellas B. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009 Dec;13(10):881-9. doi: 10.1007/s12603-009-0246-z.
- Middleton A, Fritz SL, Lusardi M. Walking speed: the functional vital sign. J Aging Phys Act. 2015 Apr;23(2):314-22. doi: 10.1123/japa.2013-0236. Epub 2014 May 2.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
1 de mayo de 2026
Finalización primaria (Estimado)
15 de mayo de 2026
Finalización del estudio (Estimado)
30 de agosto de 2026
Fechas de registro del estudio
Enviado por primera vez
25 de abril de 2026
Primero enviado que cumplió con los criterios de control de calidad
25 de abril de 2026
Publicado por primera vez (Actual)
1 de mayo de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
1 de mayo de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
25 de abril de 2026
Última verificación
1 de abril de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 2026/46
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .